Davide Capodanno/LinkedIn
Sep 30, 2025, 15:56
Davide Capodanno: Left Atrial Appendage Occlusion – the CLOSURE-AF Trial
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, posted on X:
”Left atrial appendage occlusion is a valuable option for selected high-risk patients.
Recent trials support its safety and effectiveness, but wider adoption will require stronger evidence.
The next step in this evolving field is the CLOSURE-AF trial, to be presented at AHA 25.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:23Joseph R. Shaw: Thrombin Generation and the Pharmacodynamics of Oral Anticoagulants